Ellington Management Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,300	Closed	-$248K	–	93
2020 Q1	$248K	Buy	+15,300	New	+$248K	0.06%	364
2018 Q2	–	Sell	-13,600	Closed	-$150K	–	542
2018 Q1	$150K	Buy	+13,600	New	+$150K	0.01%	747